Synthetic community [SynCom] transfer for the...
A Novel Drug to Beat a Superbug: Can Metal Nanoparticles Defeat the Antimicrobial Resistance of the Emerging Candida Auris Pathogen?
Candida auris – an emerging fungal pathogen akin to a superbug – is categorized a public health threat due to its rapid spread, ability to colonise the skin and hospital surfaces and to cause invasive disease with a high (60%) mortality rate and multi-drug resistance. New drugs are urgently needed, and in this project, we will investigate the potential of metal (e.g. silver, copper) nanoparticles as novel anti-C.auris agents. C. auris biofilms will be produced, nanoparticle-biofilm interactions will be characterized, the ability of nanoparticles to disrupt biofilms and kill the fungus will be measured and optimal nanoparticle properties will be established.
Disciplines and Techniques
Project supervisor/s
Dr. Sudaxshina Murdan
Sudaxshina is interested in the delivery of drugs, delivery of vaccines, pharmacy and pharmacy education.
University College London
Professor Sanjib Bhakta
Sanjib's research interests have focused on tackling antimicrobial resistance in global infectious bacterial pathogens including Mycobacterium tuberculosis.
Birkbeck University of London
References
Candida auris: An emerging pathogen “incognito”?
PLOS PATHOGENS 15, 4 : e1007638
2019
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen
MEDICAL MYCOLOGY, 57, 1, 1-12
2019
The comparative efficacy of antiseptics against Candida auris biofilms
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 52, 5, 673-677
2018
Candida auris and non-albicans biofilms,
MEDICAL MYCOLOGY 56, 2, S16-S16, S7.1a
2018
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
EMERGING INFECTIOUS DISEASES 23, 2, 328-331
2017